Welcome to our dedicated page for OMNICELL SEC filings (Ticker: OMCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OMNICELL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OMNICELL's regulatory disclosures and financial reporting.
Ghoshal Kaushik reported acquisition or exercise transactions in this Form 4 filing.
OMNICELL, INC. director Kaushik Ghoshal received a grant of restricted common stock as equity compensation for Board service. The grant covers 4,603 shares at no purchase price under the company’s equity incentive plan and Board of Directors Compensation Plan, bringing his direct holdings to 19,123 shares.
The restricted shares are scheduled to vest in full on the one-year anniversary of the June 1, 2026 grant date. This is a compensation-related award, not an open-market stock purchase or sale, and therefore does not reflect a discretionary trading decision in the company’s shares.
Garrett Mary reported acquisition or exercise transactions in this Form 4 filing.
Omnicell director Mary Garrett received a grant of 5,027 shares of common stock as compensation for Board service under the company’s equity incentive and Board compensation plans. The restricted shares were awarded at no cash cost and will vest in full on the one-year anniversary of the grant date, bringing her direct holdings to 22,202 shares.
Omnicell, Inc. reported results of its 2026 Annual Meeting and related governance changes. Stockholders approved an amendment to the 2009 Equity Incentive Plan that adds 1,600,000 shares of common stock authorized for issuance under the plan, increasing the pool available for equity-based compensation.
Stockholders elected Joanne B. Bauer, Robin G. Seim and Eileen J. Voynick as Class I directors to serve until the 2029 Annual Meeting. They also approved, on an advisory basis, named executive officer compensation, and ratified Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
The company amended its Amended and Restated Certificate of Incorporation to provide exculpation from personal liability for certain officers as permitted by Delaware law and to make minor non-substantive updates, following prior approval by the Board and stockholders.
Omnicell EVP and COO Nnamdi Njoku reported an open-market sale of 3,090 shares of common stock at $43.22 per share. In a separate transaction, 3,660 shares were withheld to cover taxes upon vesting of restricted stock units. After these transactions, he directly holds about 154,785 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Omnicell, Inc. VP and Chief Accounting Officer Brian H. Nutt reported a routine tax-related share disposition. On this Form 4, 226 shares of common stock were withheld at $43.12 per share to cover taxes due upon vesting of restricted stock units. After this withholding, he directly holds 22,859.6135 shares, and there was no open-market buy or sell transaction.
OMNICELL, INC. executive Corey J. Manley, EVP and Chief Legal/Admin Officer, reported two transactions in company common stock. He sold 5,025 shares in an open-market trade at an exact price of $43.22 per share pursuant to a pre-arranged Rule 10b5-1 trading plan. Separately, 4,041 shares were withheld to cover taxes due on vesting of restricted stock units. After these transactions, he directly holds about 112,783 common shares.
OMNICELL, INC. Chairman, President and CEO Randall A. Lipps reported a tax-related share disposition. On May 15, 2026, 12,347 shares of common stock were withheld at $43.12 per share to cover taxes due upon the vesting of restricted stock units.
After this withholding, he directly holds about 523,184.0741 shares of Omnicell common stock. He also reports indirect holdings of 8,051 shares in a trust for his children and 355,861 shares in a trust with his wife.
OMCL submitted a Form 144 notice reporting a proposed sale of 5,025 shares of Common Stock tied to restricted stock vesting on 05/15/2026. The filing lists Fidelity Brokerage Services LLC as the broker and shows shares outstanding of 45,478,909 shares as of 05/18/2026. The filing also discloses a prior sale of 7,405 shares on 03/16/2026 with proceeds of $256,879.45.
Omnicell, Inc. reported that multiple Wellington entities collectively hold 2,707,046 shares of its common stock, representing 5.96% of the class as of 03/31/2026. The filing attributes shared voting power of 1,808,062 and shared dispositive power of 2,707,046 among the reporting entities.